当前位置:主页 > 医学论文 > 急救医学论文 >

环磷腺苷葡胺治疗急性心肌梗死的临床观察

发布时间:2019-02-11 21:06
【摘要】:目的:探讨环磷腺苷葡胺治疗急性心肌梗死的临床疗效及安全性。方法:选择2015年5月-2016年1月我院收治的急性心肌梗死患者80例,按随机数字表法分为对照组和观察组,各40例。对照组患者予以常规治疗;观察组患者在对照组的基础上加用环磷腺苷葡胺注射液120 mg加入5%葡萄糖注射液250 m L中,ivgtt,qd。两组患者均治疗7 d。观察两组患者临床疗效及治疗前后血清超敏C反应蛋白(hs-CRP)、N末端脑利钠肽前体(NT-pro BNP)水平,并记录两组患者不良反应发生情况。结果:观察组患者临床总有效率(92.50%)显著高于对照组(75.00%),差异有统计学意义(P0.05)。治疗前,两组患者血清hs-CRP、NT-pro BNP水平比较,差异无统计学意义(P0.05);治疗后,两组患者血清hs-CRP、NT-pro BNP水平均显著降低,且观察组水平显著低于对照组,差异均有统计学意义(P0.05)。两组患者不良反应发生率比较,差异无统计学意义(P0.05)。结论:环磷腺苷葡胺治疗急性心肌梗死疗效显著,能明显降低患者血清hs-CRP和NT-pro BNP水平,且安全性较高。
[Abstract]:Objective: to investigate the clinical efficacy and safety of meglumine cyclophosphate in the treatment of acute myocardial infarction. Methods: 80 patients with acute myocardial infarction from May 2015 to January 2016 were randomly divided into control group (n = 40) and observation group (n = 40). The patients in the control group were treated with routine therapy, and the patients in the observation group were treated with adenosine cyclophosphate injection (120 mg) and 5% glucose injection (250ml) on the basis of the control group, and ivgtt,qd. was added to the control group. Both groups were treated for 7 days. The clinical efficacy and serum levels of hs-CRP), N terminal brain natriuretic peptide precursor (NT-pro BNP) were observed before and after treatment, and the adverse reactions of the two groups were recorded. Results: the total effective rate of the observation group (92.50%) was significantly higher than that of the control group (75.00%), the difference was statistically significant (P0.05). Before treatment, there was no significant difference in serum hs-CRP,NT-pro BNP levels between the two groups (P0.05). After treatment, the serum hs-CRP,NT-pro BNP levels of the two groups were significantly decreased, and the level of observation group was significantly lower than that of the control group, the difference was statistically significant (P0.05). There was no significant difference in the incidence of adverse reactions between the two groups (P0.05). Conclusion: meglumine cyclophosphate is effective in the treatment of acute myocardial infarction and can significantly reduce the levels of hs-CRP and NT-pro BNP in serum of patients with acute myocardial infarction.
【作者单位】: 齐齐哈尔医学院附属第一医院西药局;齐齐哈尔医学院附属第一医院心血管内科;
【分类号】:R542.22

【相似文献】

相关期刊论文 前10条

1 刘红杰,康腊梅,辛红梅;环磷腺苷葡胺治疗慢性充血性心力衰竭30例分析[J];中国药物与临床;2004年08期

2 杨晓君,李晓峰,郝爱华;环磷腺苷葡胺治疗老年充血性心力衰竭疗效观察[J];山东医药;2005年13期

3 郑崇杰,王刘芬;环磷腺苷葡胺治疗慢性肺心病心力衰竭56例[J];实用心脑肺血管病杂志;2005年06期

4 樊启明;;环磷腺苷葡胺治疗慢性充血性心力衰竭疗效观察[J];海南医学;2008年11期

5 王河;安胜利;谷勇杰;;环磷腺苷葡胺治疗慢性充血性心力衰竭142例疗效观察[J];当代医学;2009年34期

6 王河;安胜利;谷勇杰;;环磷腺苷葡胺治疗病态窦房结综合征256例疗效观察[J];当代医学;2009年36期

7 张丽萍;柳永华;张浩;;环磷腺苷葡胺治疗慢性充血性心力衰竭疗效观察[J];内蒙古中医药;2009年11期

8 卢建梅;;环磷腺苷葡胺注射液治疗肺心病的疗效观察[J];现代医药卫生;2010年09期

9 李宏林;;环磷腺苷葡胺治疗病态窦房结综合征疗效探讨[J];中外医学研究;2011年31期

10 油瑞琴;;环磷腺苷葡胺治疗慢性收缩性心力衰竭疗效观察[J];基层医学论坛;2012年02期

相关会议论文 前3条

1 叶允仁;;血栓通联合环磷腺苷葡胺静脉滴注治疗缓慢性心律失常53例[A];2011年中华名中医论坛暨发挥中西医优势防治肿瘤高峰论坛论文集[C];2011年

2 严秀娟;;门冬氨酸钾镁与环磷腺苷葡胺注射液治疗重症肺心病并呼吸衰竭[A];2005年浙江省呼吸系病学术年会论文汇编[C];2005年

3 王强;;芪苈强心胶囊联合环磷腺苷葡胺治疗难治性心力衰竭的临床观察[A];首届中西医血管病学大会论文汇编[C];2013年

相关硕士学位论文 前2条

1 李丹;环磷腺苷葡胺诱导骨髓间充质干细胞向心肌样细胞分化的实验研究及对舒张性心力衰竭患者的疗效分析[D];济宁医学院;2016年

2 孙士涛;环磷腺苷葡胺后处理对大鼠心肌缺血再灌注损伤的保护作用[D];辽宁医学院;2011年



本文编号:2420105

论文下载
论文发表
教材专著
专利申请


    下载步骤:
    1.微信扫码,备注编号 2420105.
    2.
    点击下载


    本文链接:http://www.bigengculture.com/yixuelunwen/jjyx/2420105.html